Cognitive impairment, including decreased attention and memory, remains one of the most disabling aspects of schizophrenia, ...

Alto Neuroscience, Inc. ("Alto") (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced the ...

Cognitive impairment, including decreased attention and memory, remains one of the most disabling aspects of schizophrenia, affecting social life of patients. However, no effective treatment has yet ...

Please provide your email address to receive an email when new articles are posted on . Memory, attention and psychomotor speed were the most frequently affected cognitive domains linked to MRI ...

Researchers assessed whether early autonomic burden is associated with incident cognitive impairment in patients with prodromal Parkinson disease.

Cognitive impairment, including decreased attention and memory, remains one of the most disabling aspects of schizophrenia, affecting social life of patients. However, no effective treatment has yet ...

In the recreation room at Eskaton Village in Carmichael, Bonnie Dale, one of the residents, is trying on a virtual reality ...

Table 1. Summary of medical therapy (chemotherapy and aromatase inhibitors) and measurements of cognitive functioning (neuropsychological testing and functional imaging) and potential confounders ...

Canine Cognitive Dysfunction (CCD) is a neurodegenerative syndrome affecting aged dogs and is considered the animal counterpart to human dementia, particularly Alzheimer’s disease. CCD manifests as ...

In 2023, 9.8% of Louisiana seniors over the age of 65 reported having difficulty remembering, concentrating or making ...